Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
DR0M3F
|
|||
| Drug Name |
CEA CAR-T
|
|||
| Drug Type |
CAR T Cell Therapy
|
|||
| Indication | Ascites [ICD-11: ME04; ICD-10: R18] | Phase 1 | [1] | |
| Peritoneal metastasis [ICD-11: 2D91] | Phase 1 | [1] | ||
| Company |
Sorrento Therapeutics
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Carcinoembryonic antigen CEA (CD66e) | Target Info | . | [1] |
| NetPath Pathway | TGF_beta_Receptor Signaling Pathway | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of Sorrento Therapeutics. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.